|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 36.75 USD | -0.14% |
|
-5.55% | +31.81% |
| 08-25 | Septerna, Inc. Announces Appointment of Rajiv Patni as Chief Medical Officer | CI |
| 08-10 | Septerna Q2 Loss Narrows, Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.72B | - | - | |||
| 48.93B | |||||
| 45.01B | - | - | - | - | - |
| 44.07B | |||||
| 40.73B | |||||
| 33.52B |
- Stock Market
- Stocks
- SEPN Stock
- Charts Septerna, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
